Literature DB >> 33757447

Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration.

Thomas Richard Johansen Forshaw1,2, Alexandra Kalia Parpounas3, Torben Lykke Sørensen3,4.   

Abstract

BACKGROUND: Visual acuity is commonly used as a functional outcome measure in patients with age-related macular degeneration (AMD), despite having a weak correlation with self-perceived visual quality of life. Microperimetry is a useful method of detecting loss of macular function. We wanted to investigate the relationship between these two objective visual outcome measures and subjective vision-related quality of life, finding out which objective measure is more patient-relevant.
METHODS: Fifty-one consecutive patients with AMD were recruited to the study. Participants were required to complete the Visual Function Questionnaire 39, the Early Treatment Diabetic Retinopathy Study visual acuity examination and a microperimetry assessment using the Micro Perimeter 3. One patient withdrew consent and seven patients dropped out due to cooperation difficulties under microperimetry. Forty-three patients with AMD were included in the study: twenty-eight patients with late AMD (exudative AMD) and fifteen patients with early (non-exudative) AMD. The right eye was included as standard, as was the eye with the best-corrected visual acuity.
RESULTS: There was a higher correlation between vision-related quality of life and macular sensitivity (r = 0.458; p = 0.014) than between vision-related quality of life and visual acuity (r = 0.446; p = 0.018) in patients with late AMD. There was a positive correlation between vision-related quality of life and macular sensitivity in patients with early AMD (r = 0.542; p = 0.037) while the correlation between vision-related quality of life and visual acuity in these patients was not statistically significant. Composite score (r = 0.469; p = 0.012) correlated highest with the nasal outer macular sub-region and near-distance activities score (r = 0.652; p < 0.001) correlated highest with the nasal inner macular sub-region in patients with late AMD. Correlations between composite score and macular sub-regions in patients with early AMD were not significant, but near-distance activities score correlated with the nasal outer macular sub-region in these patients (r = 0.469; p = 0.012).
CONCLUSIONS: Macular sensitivity as measured using microperimetry correlates with vision-related quality of life in early AMD and in late AMD, showing it to be a patient-relevant outcome measure. Furthermore, the nasal sub-regions of the macula appear to be preferred retinal loci in patients with AMD. (338 words).

Entities:  

Keywords:  Age-related macular degeneration; Early treatment diabetic retinopathy study; Macular sensitivity; Microperimetry; Vision-related quality of life; Visual acuity; Visual function questionnaire 39

Mesh:

Year:  2021        PMID: 33757447      PMCID: PMC7988949          DOI: 10.1186/s12886-021-01901-x

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  42 in total

1.  Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema.

Authors:  K Okada; S Yamamoto; S Mizunoya; A Hoshino; M Arai; Y Takatsuna
Journal:  Eye (Lond)       Date:  2005-07-15       Impact factor: 3.775

2.  Danish version of Visual Function Questionnaire-25 and its use in age-related macular degeneration.

Authors:  Mette Sejer Sørensen; Susanne Andersen; Gitte Osterby Henningsen; Charlotte Thornby Larsen; Torben Lykke Sørensen
Journal:  Dan Med Bull       Date:  2011-06

3.  Structural Changes Associated with Delayed Dark Adaptation in Age-Related Macular Degeneration.

Authors:  Inês Laíns; John B Miller; Dong H Park; Edem Tsikata; Samaneh Davoudi; Safa Rahmani; Jonathan Pierce; Rufino Silva; Teresa C Chen; Ivana K Kim; Demetrios Vavvas; Joan W Miller; Deeba Husain
Journal:  Ophthalmology       Date:  2017-05-10       Impact factor: 12.079

4.  Electrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degeneration.

Authors:  Karen Bjerg Pedersen; Flemming Møller; Anne Katrin Sjølie; Sten Andréasson
Journal:  Retina       Date:  2010 Jul-Aug       Impact factor: 4.256

5.  Cataract surgery in patients with bilateral advanced age-related macular degeneration: Measurement of visual acuity and quality of life.

Authors:  Yingyan Ma; Jiannan Huang; Bijun Zhu; Qian Sun; Yuyu Miao; Haidong Zou
Journal:  J Cataract Refract Surg       Date:  2015-06       Impact factor: 3.351

6.  The role of the ERG in the diagnosis and treatment of Age-Related Macular Degeneration.

Authors:  Christina Gerth
Journal:  Doc Ophthalmol       Date:  2008-06-07       Impact factor: 2.379

7.  Fixation stability measurement using the MP1 microperimeter.

Authors:  Michael D Crossland; Hannah M P Dunbar; Gary S Rubin
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

Review 8.  Senile macular degeneration: review of epidemiologic features.

Authors:  F L Ferris
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

9.  Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts.

Authors:  Iryna A Falkenstein; Denine E Cochran; Stanley P Azen; Laurie Dustin; Ajay M Tammewar; Igor Kozak; William R Freeman
Journal:  Ophthalmology       Date:  2007-08-13       Impact factor: 12.079

10.  Individual Test Point Fluctuations of Macular Sensitivity in Healthy Eyes and Eyes With Age-Related Macular Degeneration Measured With Microperimetry.

Authors:  Mirella Telles Salgueiro Barboni; Zsuzsanna Szepessy; Dora Fix Ventura; János Németh
Journal:  Transl Vis Sci Technol       Date:  2018-04-23       Impact factor: 3.283

View more
  1 in total

1.  Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema.

Authors:  Taro Otawa; Hidetaka Noma; Kanako Yasuda; Akitomo Narimatsu; Masaki Asakage; Akina Tanaka; Hiroshi Goto; Masahiko Shimura
Journal:  BMC Ophthalmol       Date:  2022-06-04       Impact factor: 2.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.